REG3G

Across TCGA pan-cancer cohorts, REG3G mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated REG3G data layer compared with 17 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher REG3G mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated REG3G expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.

PDAC are the cancer types where REG3G mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Quartile	III,IV	0.834	0.241	.013	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

REG3G–PDAC (DFS)

Open the PDAC breakdown →